ATXN7L3 positively regulates SMAD7 transcription in hepatocellular carcinoma with growth inhibitory function

Background: Hepatocellular carcinoma (HCC) is a leading cause of cancer death worldwide, with unmet need for the pharmacological therapy. The functions of ATXN7L3 in HCC progression are not known. Methods: RNA sequence, quantitative real-time PCR, and western blot were performed to detect gene expre...

Full description

Bibliographic Details
Main Authors: Ning Sun, Xinping Zhong, Shengli Wang, Kai Zeng, Hongmiao Sun, Ge Sun, Renlong Zou, Wei Liu, Wensu Liu, Lin Lin, Huijuan Song, Chi Lv, Chunyu Wang, Yue Zhao
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:EBioMedicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396420304849
id doaj-a5675bb3581c455f995a8d0fde6fbf48
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Ning Sun
Xinping Zhong
Shengli Wang
Kai Zeng
Hongmiao Sun
Ge Sun
Renlong Zou
Wei Liu
Wensu Liu
Lin Lin
Huijuan Song
Chi Lv
Chunyu Wang
Yue Zhao
spellingShingle Ning Sun
Xinping Zhong
Shengli Wang
Kai Zeng
Hongmiao Sun
Ge Sun
Renlong Zou
Wei Liu
Wensu Liu
Lin Lin
Huijuan Song
Chi Lv
Chunyu Wang
Yue Zhao
ATXN7L3 positively regulates SMAD7 transcription in hepatocellular carcinoma with growth inhibitory function
EBioMedicine
ATXN7L3
Estrogen receptor α
Co-regulator
Deubiquitination modification
Hepatocellular carcinoma
author_facet Ning Sun
Xinping Zhong
Shengli Wang
Kai Zeng
Hongmiao Sun
Ge Sun
Renlong Zou
Wei Liu
Wensu Liu
Lin Lin
Huijuan Song
Chi Lv
Chunyu Wang
Yue Zhao
author_sort Ning Sun
title ATXN7L3 positively regulates SMAD7 transcription in hepatocellular carcinoma with growth inhibitory function
title_short ATXN7L3 positively regulates SMAD7 transcription in hepatocellular carcinoma with growth inhibitory function
title_full ATXN7L3 positively regulates SMAD7 transcription in hepatocellular carcinoma with growth inhibitory function
title_fullStr ATXN7L3 positively regulates SMAD7 transcription in hepatocellular carcinoma with growth inhibitory function
title_full_unstemmed ATXN7L3 positively regulates SMAD7 transcription in hepatocellular carcinoma with growth inhibitory function
title_sort atxn7l3 positively regulates smad7 transcription in hepatocellular carcinoma with growth inhibitory function
publisher Elsevier
series EBioMedicine
issn 2352-3964
publishDate 2020-12-01
description Background: Hepatocellular carcinoma (HCC) is a leading cause of cancer death worldwide, with unmet need for the pharmacological therapy. The functions of ATXN7L3 in HCC progression are not known. Methods: RNA sequence, quantitative real-time PCR, and western blot were performed to detect gene expression. Chromatin immunoprecipitation was performed to detect possible mechanisms. Immunohistochemical stain was performed to examine the protein expression. Colony formation, cell growth curve and xenograft tumor experiments were performed to examine cell growth in vitro and in vivo. Findings: ATXN7L3 functions as a coactivator for ERα-mediated transactivation in HCC cells, thereby contributing to enhanced SMAD7 transcription. ATXN7L3 is recruited to the promoter regions of SMAD7 gene, thereby regulating histone H2B ubiquitination level, to enhance the transcription of SMAD7. A series of genes regulated by ATXN7L3 were identified. Moreover, ATXN7L3 participates in suppression of tumor growth. In addition, ATXN7L3 is lower expressed in HCC samples, and the lower expression of ATXN7L3 positively correlates with poor clinical outcome in patients with HCC. Interpretation: This study demonstrated that ATXN7L3 is a novel regulator of SMAD7 transcription, subsequently participating in inhibition of tumor growth in HCC, which provides an insight to support a previously unknown role of ATXN7L3 in HCC progression. Fund: This work was funded by 973 Program Grant from the Ministry of Science and Technology of China (2013CB945201), National Natural Science Foundation of China (31871286, 81872015, 31701102, 81702800, 81902889), Foundation for Special Professor of Liaoning Province, Natural Science Foundation of Liaoning Province (No.20180530072); China Postdoctoral Science Foundation (2019M651164).
topic ATXN7L3
Estrogen receptor α
Co-regulator
Deubiquitination modification
Hepatocellular carcinoma
url http://www.sciencedirect.com/science/article/pii/S2352396420304849
work_keys_str_mv AT ningsun atxn7l3positivelyregulatessmad7transcriptioninhepatocellularcarcinomawithgrowthinhibitoryfunction
AT xinpingzhong atxn7l3positivelyregulatessmad7transcriptioninhepatocellularcarcinomawithgrowthinhibitoryfunction
AT shengliwang atxn7l3positivelyregulatessmad7transcriptioninhepatocellularcarcinomawithgrowthinhibitoryfunction
AT kaizeng atxn7l3positivelyregulatessmad7transcriptioninhepatocellularcarcinomawithgrowthinhibitoryfunction
AT hongmiaosun atxn7l3positivelyregulatessmad7transcriptioninhepatocellularcarcinomawithgrowthinhibitoryfunction
AT gesun atxn7l3positivelyregulatessmad7transcriptioninhepatocellularcarcinomawithgrowthinhibitoryfunction
AT renlongzou atxn7l3positivelyregulatessmad7transcriptioninhepatocellularcarcinomawithgrowthinhibitoryfunction
AT weiliu atxn7l3positivelyregulatessmad7transcriptioninhepatocellularcarcinomawithgrowthinhibitoryfunction
AT wensuliu atxn7l3positivelyregulatessmad7transcriptioninhepatocellularcarcinomawithgrowthinhibitoryfunction
AT linlin atxn7l3positivelyregulatessmad7transcriptioninhepatocellularcarcinomawithgrowthinhibitoryfunction
AT huijuansong atxn7l3positivelyregulatessmad7transcriptioninhepatocellularcarcinomawithgrowthinhibitoryfunction
AT chilv atxn7l3positivelyregulatessmad7transcriptioninhepatocellularcarcinomawithgrowthinhibitoryfunction
AT chunyuwang atxn7l3positivelyregulatessmad7transcriptioninhepatocellularcarcinomawithgrowthinhibitoryfunction
AT yuezhao atxn7l3positivelyregulatessmad7transcriptioninhepatocellularcarcinomawithgrowthinhibitoryfunction
_version_ 1724386930819334144
spelling doaj-a5675bb3581c455f995a8d0fde6fbf482020-12-11T04:22:20ZengElsevierEBioMedicine2352-39642020-12-0162103108ATXN7L3 positively regulates SMAD7 transcription in hepatocellular carcinoma with growth inhibitory functionNing Sun0Xinping Zhong1Shengli Wang2Kai Zeng3Hongmiao Sun4Ge Sun5Renlong Zou6Wei Liu7Wensu Liu8Lin Lin9Huijuan Song10Chi Lv11Chunyu Wang12Yue Zhao13Department of Cell Biology, Key laboratory of Cell Biology, Ministry of Public Health, and Key laboratory of Medical Cell Biology, Ministry of Education, School of Life Sciences, China Medical University, Shenyang City, Liaoning Province 110122, ChinaDepartment of General Surgery, the First Affiliated Hospital of China Medical University, Shenyang City, Liaoning Province, 110001, ChinaDepartment of Cell Biology, Key laboratory of Cell Biology, Ministry of Public Health, and Key laboratory of Medical Cell Biology, Ministry of Education, School of Life Sciences, China Medical University, Shenyang City, Liaoning Province 110122, ChinaDepartment of Cell Biology, Key laboratory of Cell Biology, Ministry of Public Health, and Key laboratory of Medical Cell Biology, Ministry of Education, School of Life Sciences, China Medical University, Shenyang City, Liaoning Province 110122, ChinaDepartment of Cell Biology, Key laboratory of Cell Biology, Ministry of Public Health, and Key laboratory of Medical Cell Biology, Ministry of Education, School of Life Sciences, China Medical University, Shenyang City, Liaoning Province 110122, ChinaDepartment of Cell Biology, Key laboratory of Cell Biology, Ministry of Public Health, and Key laboratory of Medical Cell Biology, Ministry of Education, School of Life Sciences, China Medical University, Shenyang City, Liaoning Province 110122, ChinaDepartment of Cell Biology, Key laboratory of Cell Biology, Ministry of Public Health, and Key laboratory of Medical Cell Biology, Ministry of Education, School of Life Sciences, China Medical University, Shenyang City, Liaoning Province 110122, ChinaDepartment of Cell Biology, Key laboratory of Cell Biology, Ministry of Public Health, and Key laboratory of Medical Cell Biology, Ministry of Education, School of Life Sciences, China Medical University, Shenyang City, Liaoning Province 110122, ChinaDepartment of Cell Biology, Key laboratory of Cell Biology, Ministry of Public Health, and Key laboratory of Medical Cell Biology, Ministry of Education, School of Life Sciences, China Medical University, Shenyang City, Liaoning Province 110122, ChinaDepartment of Cell Biology, Key laboratory of Cell Biology, Ministry of Public Health, and Key laboratory of Medical Cell Biology, Ministry of Education, School of Life Sciences, China Medical University, Shenyang City, Liaoning Province 110122, ChinaDepartment of Cell Biology, Key laboratory of Cell Biology, Ministry of Public Health, and Key laboratory of Medical Cell Biology, Ministry of Education, School of Life Sciences, China Medical University, Shenyang City, Liaoning Province 110122, ChinaDepartment of Cell Biology, Key laboratory of Cell Biology, Ministry of Public Health, and Key laboratory of Medical Cell Biology, Ministry of Education, School of Life Sciences, China Medical University, Shenyang City, Liaoning Province 110122, China; Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang City, Liaoning Province, 110004, ChinaDepartment of Cell Biology, Key laboratory of Cell Biology, Ministry of Public Health, and Key laboratory of Medical Cell Biology, Ministry of Education, School of Life Sciences, China Medical University, Shenyang City, Liaoning Province 110122, China; Corresponding author.Department of Cell Biology, Key laboratory of Cell Biology, Ministry of Public Health, and Key laboratory of Medical Cell Biology, Ministry of Education, School of Life Sciences, China Medical University, Shenyang City, Liaoning Province 110122, China; Department of Endocrinology and Metabolism, Institute of Endocrinology, The First Affiliated Hospital of China Medical University, Shenyang City, Liaoning Province 110001, China; Corresponding author.Background: Hepatocellular carcinoma (HCC) is a leading cause of cancer death worldwide, with unmet need for the pharmacological therapy. The functions of ATXN7L3 in HCC progression are not known. Methods: RNA sequence, quantitative real-time PCR, and western blot were performed to detect gene expression. Chromatin immunoprecipitation was performed to detect possible mechanisms. Immunohistochemical stain was performed to examine the protein expression. Colony formation, cell growth curve and xenograft tumor experiments were performed to examine cell growth in vitro and in vivo. Findings: ATXN7L3 functions as a coactivator for ERα-mediated transactivation in HCC cells, thereby contributing to enhanced SMAD7 transcription. ATXN7L3 is recruited to the promoter regions of SMAD7 gene, thereby regulating histone H2B ubiquitination level, to enhance the transcription of SMAD7. A series of genes regulated by ATXN7L3 were identified. Moreover, ATXN7L3 participates in suppression of tumor growth. In addition, ATXN7L3 is lower expressed in HCC samples, and the lower expression of ATXN7L3 positively correlates with poor clinical outcome in patients with HCC. Interpretation: This study demonstrated that ATXN7L3 is a novel regulator of SMAD7 transcription, subsequently participating in inhibition of tumor growth in HCC, which provides an insight to support a previously unknown role of ATXN7L3 in HCC progression. Fund: This work was funded by 973 Program Grant from the Ministry of Science and Technology of China (2013CB945201), National Natural Science Foundation of China (31871286, 81872015, 31701102, 81702800, 81902889), Foundation for Special Professor of Liaoning Province, Natural Science Foundation of Liaoning Province (No.20180530072); China Postdoctoral Science Foundation (2019M651164).http://www.sciencedirect.com/science/article/pii/S2352396420304849ATXN7L3Estrogen receptor αCo-regulatorDeubiquitination modificationHepatocellular carcinoma